They showed that GLUT inhibition by phloretin reduces tumor growth and enables sorafenib sensitization in xenograft mice injected with CD133+ enriched Huh-7 cells, highlighting the beneficial effect of this combination strategy in stem cell-like HCCs [40]. Here, SLC2A1 is linked to neoplasm.